Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Again your trying to persuade based on assumptions and your model of valuation.
No complaints. Only observations and providing direct replies to your assumptions.
Adios!
You have not mentioned that the warrants have non-dilution preventive restrictions in place, nor have you mentioned that the warrants are callable if the PPS stays over $5 for 10 consecutive days. You didn't mention the retirement of longer term debt. You haven't mentioned that the main increase other expenses for Q3 was basically due to the issuance of warrants and retirement of debt which are considered to be non-cash expenses and a one time occurrence that effected the EPS. You have not mentioned that there has been no evidence of any significant dilution over the past 4 qtrs and that the float has stayed at its current level.
You certainly are worried for an analyst and be on a message board trying persuade others of your theories.
I'm out. The bars, music, and drinks beckon!
Will be back tomorrow to clean up any mess you leave here.
GN all....
Alan - as you know, or I think you know, had it not been for the OTC having to step in and request CANN to issue a release regarding the marketing piece that CANN had no knowledge of, CANN would be sitting between $6 to $8 per share today.
Let me say it clearly, CANN is not a blue chip stock. It is an emerging market stock. It takes balls and courage to invest in and grow within the MJ sector.
I was going to say, "you know as well as I do", but as I think about it, maybe you don't.
CANN has improved its position every damn quarter I've been around. And today they are poised to open offices in Cali, Oregon, and Washington, in addition to acquiring another company and continue its expansion.
Alan, there's no convincing you. So short the stock. Put your house up for sale and short it. You'd make a fortune, right? Short it and post your confirmation on here or your website. Please advise your customers to short it too.
Yeah, I know. It's policies for you guys not to have any positions. But you stand to make millions. That would be better than the 24k annual salary you have.
Let me know.
One last thing. The appointment of Sessions won't change any of the dynamics in the MJ legalization for states. It'll only improve from here. I'm on record.
Again, your using assumptions and guessing to say insiders converted and sold shares for the purpose of avoiding a mass conversion which is only a small portion of their holdings. And your also stating the stock will be down at a lower lever if and when these conversions happen.
You've also stated there's not going to be any acquisitions due to lack of funds and no resources.
You've also stated they won't have money to keep the lights on in 10 weeks yet management keeps hiring.
Let me post my earlier post again.
We've already seen at least 2 BUY RECOMMENDATIONS placed on the stock based on reviews of CANN financials and seeing the company at the Vegas event. Waiting for further news this coming week to flow in.
One announcement from CANN is all it takes.
He has no clue. He's guessing the stock price will fall in suit with others such as AMMJ and it will trigger conversions.
I want him to show proof he's short the stock. I will use every resource to give him and his customers a margin call a day.
He's a con artist nothing more. I took his argument to a UBS analyst and he basically called it a crock.
If Trump wants 4% GDP growth he will let MJ and CANN flourish. Like I said, nothing will slow the MJ legalization train. Not Sessions nor Alan Borch.
Alan - as you know, or I think you know, had it not been for the OTC having to step in and request CANN to issue a release regarding the marketing piece that CANN had no knowledge of, CANN would be sitting between $6 to $8 per share today.
Let me say it clearly, CANN is not a blue chip stock. It is an emerging market stock. It takes balls and courage to invest in and grow within the MJ sector.
I was going to say, "you know as well as I do", but as I think about it, maybe you don't.
CANN has improved its position every damn quarter I've been around. And today they are poised to open offices in Cali, Oregon, and Washington, in addition to acquiring another company and continue its expansion.
Alan, there's no convincing you. So short the stock. Put your house up for sale and short it. You'd make a fortune, right? Short it and post your confirmation on here or your website. Please advise your customers to short it too.
Yeah, I know. It's policies for you guys not to have any positions. But you stand to make millions. That would be better than the 24k annual salary you have.
Let me know.
One last thing. The appointment of Sessions won't change any of the dynamics in the MJ legalization for states. It'll only improve from here. I'm on record.
From the official CANN twitter account:
http://www.usatoday.com/story/money/nation-now/2016/11/18/california-marijuana-industry-25-billion-opportunity/94074848/
I think you can get the hint of which state they're about to grow into.
One more thing, the capital burn rate was far worse this time last year, yet the stock soared to $5.19. Revenues have increased at record rates during each of the past 4 quarterly reports and all divisions of CANN are just getting ramped up as they've gained greater traction. The year end Qtr 4 report will exceed earnings expectations again with yet another strong revenues jump and record pace.
They are in greater position today than ever before. And yes, they have the resources available for expansion and acquisition.
So your just guessing and your whole premise is pretty much based on warrants. Btw, yes, you are using a pricing model based on your market capitalization calculations and comparables theories such as with your use of AMMJ.
The interesting fact is, there were 3 or 4 positive recently released analysis or reviews on CANN and a couple of those came right AFTER your negative piece. It's not the fact that the others were all positive against your negative write up, it's the fact those authors are not on any message boards trying to defend their statements or convince others one way or the others.
Just find it interesting and intriguing. After all, those things do come to mind when you're not an ostrich with its head in the sand.
As I have stated, you're models are incorrect and misleading regarding CANN. Again, your use of scare tactics is evident in your comments with Sessions. Of course people are concerned with the AG nomination.
But the point I made was Sessions will not infringe on state sovereignty laws and rights, you then said "if he had his way" which is not a statement of what will actually happen, but a scare tactic.
You did not directly answer my question on when dilution from warrants what the PPS would be but instead placed short term price targets for December and March 2017.
I hear ya dude.
BTW - a good friend and colleague of mine over at UBS disagrees with your valuation method and dilution theory as do I.
Let's get it rolling here.
What will be the price per share of CANN when any significant conversions of warrants will actually happen?
Alan Borch - I've asked several questions directly to you. Will you please respectfully answer those that I've asked.
Sessions is not going to infringe on state sovereignty rights. You know it as well as I do.
You've got to do better than scare tactics.
After researching and looking at Sessions as AG, their MO appears to pull back federal over reaching and be more state friendly and allow states more freedom and responsibilities to handle laws and regulations. With that premise, I'm extremely confident there's not going to be any momentum detriments to the MJ sector.
I'm certain the number 1 area of concern and aim of the Justice admin will be immigration laws. And that will rely on most of their resources of DOJ and other arms of justice dept. They have very limited resources. This will consume the majority of their focus.
I agree. There is a cloud of uncertainty, not just in the MJ community, but in just about every aspect of business related to laws and regulations.
Ah the memories. Aces and Eights on Friday's NYC. And in my days this would be blaring....
Aren't all of us here wanted dead or alive? In the end, CANN will get us there. Believe it!!!
Have a great weekend.
Oh it's coming. Zero doubts. You have a great weekend! You damn sure deserve one.
I suspect we will hear more from analysts and I'm looking for some institutional presence in the trading week.
The acquisition is coming. Then boom!
That's a good day. Guess the whole 2 dudes that follow Alan Borch turned their backs on him.
Here goes......
Well I walk the streets
With a 6 string on my back
I play for keeps cause I might not make it back!!!!!
Let's roll!!!
On a steel horse I ride
I'm wanted
Dead or alive.....
The industry will not slow its roll because of any AG.
Read my posts about AMMJ and CANN. AMMJ is not even in the same subdivision with CANN. Wish nothing but the best for AMMJ shareholders, but can is an elite breed by comparison.
It's a flagrant lie told by Alan. Borderline criminal. He's nothing more than a 2 bit crook that has probably swindled his own family out of money. That's no way to make a living.
One thing is perfectly clear, every new release prominently states acquisitions are coming soon. This really has me stoked!
Yes, and someone is gobbling up the shares. Very peculiar happening right now.
He was exposed. I'm here if he wants to compare brain pans. Truth is, most investors are much more savvy than they give themselves credit for. It just comes down to confidence.
And I listen to you guys talk and I am still always opened to learn more. Lot of good chatter here.
Someone is gobbling up shares of CANN as we move up against limits.
Got a proxy fight at $3.80. Love it! Here's a first in a week. Break through this and limits are now back up to, yup, you guessed. $4.20.
It's Friday! Just remember......
It's a long way to the top if you want to rock n roll!!!!
Boockvar is a huge asset for CANN. He's worth it.
He sold his shares ahead of good news. He can not sell after a great news and a hyped up stock price for fear of insider trading and ethical behavior.
And he sold his shares after the release of Q3 earnings. He did right.
Warlon - first thing, the story by Insider Financial posted below is the first of so many positive outcomes that will be derived from the Vegas event. Management is going full tilt. Getting the word out to analysts, institutional investors, and future business prospects. These positive results are going to be seen daily from here thru December going into 2017.
Nah, just let Broch be and deal with him on our turf if he wants to play fair. I answered his question, though he won't answer mine. Integrity is something that's been missing on WS, we can show him and others that this board right here is proof that sharing information can bring different ideas together for a stronger understanding of CANN when the discussion is truthful, fair, and without undue bias.
Warlon, you're the man with news flow! Thanks in advance for all the info that's coming from you!!
Yes. Here's the reason CANN is still undervalued in my opinion. Current position to grow, strong diversified platform, past actuals and future expected revenue growth, and strong management.
Still should be trading between $6 to $8 before first acquisition.
Broch or Borch - Now that writer/analyst understands micro caps. The article just released and damn well nearly puts my words and thoughts verbatim in it. Study it. Learn it. Or else you might hurt people by losing their money.
Why is it that my analysis with over 30 years experience sounds so close to that article yet your riding on a horse like Paul Revere yelling the dilution is coming?
Now, will you please answer my questions? Do I need to issue you warrants as a kicker to get you to answer?
Release: General Cannabis Corp (OTCMKTS:CANN) Is Way Ahead Of The Crowd In Pot Stocks
https://www.insiderfinancial.com/general-cannabis-corp-otcmktscann-is-way-ahead-of-the-crowd-in-pot-stocks/118312/
An investor seeking a diversified exposure to the burgeoning cannabis industry in the US should focus on General Cannabis Corp (OTCMKTS:CANN). The company bills itself as an all solutions entity, and it’s exactly that. From banking, to distribution, to consulting, General Cannabis has revenue streams coming in from multiple sources, and as the industry expands on the back of the recreational push, we think the company is going to benefit from this expansion by way of growth of its own.
We just recently got an operational update, alongside some numbers, and these serve as a nice platform from which to build a thesis. Here’s are the highlights, and what we’re looking for moving forward.
First, a quick look at the chart. The chart below illustrates circa six months’ worth of action in CANN, and it’s similar to pretty much every company in the space right now, with a couple of key differences.
First, volume started to pick up much earlier than many of its so-called peers. We see this as a sign that markets pegged this one as being one of the likely strong candidates early on, and loaded up before the competition heated up (and by proxy, the price of an exposure increased). Second, that while the company rocketed ahead of the vote, it hasn’t corrected anywhere near as harshly as some of the other in the space. Again, for us, this says a lot. Yes, it’s 22% or so off highs, but that’s child’s play when you look at some of the smaller fish.
Both of these elements, for us, indicate longer term strength, and underpin a bullish bias from a technical perspective. But that’s not all, of course. The numbers point towards future strength as well.
During the third quarter of 2016 (three months ended September 30), General Cannabis generated a little over $810K revenues, with the vast majority of these revenues deriving from the service side of its operations (as opposed to tenant and product). This is up 37% on the $593K recorded a year earlier. Another highlight is the growth of the company’s product retail business, revenues from which grew more than 740% year over year third quarter, accounting for a little over $80K of the third quarter total, versus just $9.5K a year earlier.
Looking at full year, management expects approximately $3.1 million in 2016 full year revenues, compared to just $1.7 million last year. The important thing to note here is that while many companies in this space right now are basing valuations on potential revenues post legalization. General Cannabis has been expanding its top-line to a high degree before the vote took place. To put this another way, if the company can grow like this before recreational cannabis is legal in markets like California and Nevada, it can surely grow exponentially after legalization is in place (which now, of course, it is).
Cash position isn’t too bad, with the company having picked up $3 million on the back of a debt financing in September. This sort of financing isn’t great for shareholders, of course, but CANN expects to put the capital raised towards acquisition, which should serve to boost revenue potential heading into early 2017.
The bottom line here is we could go on all day about General Cannabis and its operations, its potential and its various ventures, but we could do the same about 100 other companies in the cannabis space right now that have experienced similar, or larger, gains over the last few weeks. What we couldn’t do with the others, is point to a solid thesis based on strengthening operations and expanding revenues.
With General Cannabis, we can.
There’s always a degree of risk on these ones – the run up seen across the last two months has left many players in the space overvalued to varying degrees, and that makes it tough to find companies with any run room left on current fundamentals – but we think CANN is ahead of the bunch.
Broch - wrong again. Mezzanine and private placements via loans and derivatives are a much more risky proposition than being a shareholder. Damn son. Do you have an education in finance or economics? Business in general.
Back in my days of working at Capital Holdings before moving on to WS, we took a division on the equity side from 20mm to 200mm in just a few years. By far, the mezzanine side of it was the most riskiest even with the sweeteners such as warrants. We invested primarily in emerging markets to mid caps. The emerging markets were the pockets of highest returns that took us to unreal levels. Yep, that's right. I did the analytics. And I've never seen any valuation models that discriminate the way yours does.
Yes, dilution is not considered a positive thing overall. But it occurs with just about every publically traded company especially during the early growth and expansion years. It occurs by conversions or secondary stock offerings which I've actually been a part of.
CANN has an unreasonably small float. And there hasn't been any significant dilution to date.
And there's many instances when dilution are positive in terms of allowing a company to GROW AND EXPAND.
Here's the question I'm posing to the poser here.
What will the price per share be when any significant dilution occurs? He won't answer.
I'm projecting 2017 to be an insane year of growth revenue wise. Ask Broch if a company is growing at a rapid rate to whether added shares can easily be absorbed.
Borch, again you're way off and yet haven't answered any questions whatsoever. None. Have you ever worked inside the investment field? And being a bank teller doesn't count. What firm were you with? Any? Have you ran before?
I'm still waiting for you to answer my questions.
Borch - you've not answered any of my questions. Zero. Answer this. If and when any serious dilution occurs, what will be the stock price when it occurs? Will it be the current trading range of about $3.30 to $4.60? Back at 52 week high of $5.19? $6.00 to $10.00? $20.00 plus? Give me a number.